Publication|Articles|April 18, 2025
- Pharmaceutical Executive: April 2025
- Volume 45
- Issue 3
Pharmaceutical Executive: April 2025 Interactive Digital Edition
View the Pharmaceutical Executive April 2025 issue in an interactive format.
Advertisement
Click
Articles in this issue
12 months ago
‘Earning’ Power12 months ago
Milan Kalawadia: Carving Out New Pathways12 months ago
Bringing Biotech Innovation Across Borders12 months ago
Using AI to Predict Launch Success12 months ago
The Future of DTC in Pharma12 months ago
Translating ‘Digital-First’ to Commercial Successabout 1 year ago
HEOR: From Proving Product Value to Proving Its Own WorthNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Shionogi Inc. Awarded $482 Million Contract with U.S. Government to Enhance National Preparedness for Drug-Resistant Bacterial Threats
2
Pharmaceutical Executive Daily: China Approves Amgen's Tarlatamab for Previously Treated Extensive-Stage Small Cell Lung Cancer
3
New Study Reveals Genetic Predictors for GLP-1 Weight Loss and Side Effects
4
Q&A: Supply Chain Fallout From Iran War, Tariff Uncertainty
5